IRF6 and neuroblastoma: Clinically, neuroblastoma patients with PGM1 high/IRF6 low integrated expression had the worst overall and event-free survival, emphasizing the crucial role of the IRF6-PGM1 pathway in glycolysis-dependent tumorigenesis.